Skip to main content
Fig. 9 | Cancer Cell International

Fig. 9

From: Identification and validation of eight lysosomes-related genes signatures and correlation with immune cell infiltration in lung adenocarcinoma

Fig. 9

The Characterization of the TME, immunotherapeutic and chemotherapeutic response and in different risk group. A–C The difference of TIDE score, exclusion score and dysfunction score between different risk group. D The ROC curves evaluating the predictive accuracy of the risk score in the IMvigor210 cohort. E The high-risk group had poorer prognosis than low risk group in the imvigor210 cohort. F The percentage rates of clinical response (complete response [CR]/partial response [PR] and stable disease [SD]/progressive disease [PD]) to anti–PD-L1 immunotherapy in high or low LYSscore groups in the IMvigor210

Back to article page

Cancer Cell International

ISSN: 1475-2867

Contact us